Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pamidronate effective against skeletal complications in breast cancer patients

Dec. 18, 1996

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Dec. 18, 1996

Licenses offered for the use of IL-7 in increasing hematopoietic stem cells

Dec. 17, 1996

NIH offers glycoprotein hormone superagonists for licensing

Dec. 17, 1996

Oscillin and MAbs against it offered for licensing

Dec. 17, 1996

New bile acid transporter inhibitors in preclinical testing at Searle

Dec. 16, 1996

Alanex and Novo Nordisk expand diabetes research collaboration

Dec. 16, 1996

Human growth hormone products recommended for approval

Dec. 16, 1996

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

Encouraging clinical results with MacroChem Rx for impotence

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...